Literature DB >> 36050589

Is an MRI-derived anatomical measure of dementia risk also a measure of brain aging?

Ramon Casanova1, Andrea M Anderson2, Ryan T Barnard2, Jamie N Justice3, Anna Kucharska-Newton4, Beverly Gwen Windham5, Priya Palta6, Rebecca F Gottesman7, Thomas H Mosley5, Timothy M Hughes3, Lynne E Wagenknecht8, Stephen B Kritchevsky3.   

Abstract

Machine learning methods have been applied to estimate measures of brain aging from neuroimages. However, only rarely have these measures been examined in the context of biologic age. Here, we investigated associations of an MRI-based measure of dementia risk, the Alzheimer's disease pattern similarity (AD-PS) scores, with measures used to calculate biological age. Participants were those from visit 5 of the Atherosclerosis Risk in Communities Study with cognitive status adjudication, proteomic data, and AD-PS scores available. The AD-PS score estimation is based on previously reported machine learning methods. We evaluated associations of the AD-PS score with all-cause mortality. Sensitivity analyses using only cognitively normal (CN) individuals were performed treating CNS-related causes of death as competing risk. AD-PS score was examined in association with 32 proteins measured, using a Somalogic platform, previously reported to be associated with age. Finally, associations with a deficit accumulation index (DAI) based on a count of 38 health conditions were investigated. All analyses were adjusted for age, race, sex, education, smoking, hypertension, and diabetes. The AD-PS score was significantly associated with all-cause mortality and with levels of 9 of the 32 proteins. Growth/differentiation factor 15 (GDF-15) and pleiotrophin remained significant after accounting for multiple-testing and when restricting the analysis to CN participants. A linear regression model showed a significant association between DAI and AD-PS scores overall. While the AD-PS scores were created as a measure of dementia risk, our analyses suggest that they could also be capturing brain aging.
© 2022. The Author(s), under exclusive licence to American Aging Association.

Entities:  

Keywords:  Aging; Alzheimer’s disease; Deficit accumulation index; Machine learning; Mortality; Proteomics

Year:  2022        PMID: 36050589     DOI: 10.1007/s11357-022-00650-z

Source DB:  PubMed          Journal:  Geroscience        ISSN: 2509-2723            Impact factor:   7.581


  40 in total

Review 1.  Predicting Age Using Neuroimaging: Innovative Brain Ageing Biomarkers.

Authors:  James H Cole; Katja Franke
Journal:  Trends Neurosci       Date:  2017-10-23       Impact factor: 13.837

Review 2.  A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup.

Authors:  Jamie N Justice; Luigi Ferrucci; Anne B Newman; Vanita R Aroda; Judy L Bahnson; Jasmin Divers; Mark A Espeland; Santica Marcovina; Michael N Pollak; Stephen B Kritchevsky; Nir Barzilai; George A Kuchel
Journal:  Geroscience       Date:  2018-08-27       Impact factor: 7.713

Review 3.  Reverse geroscience: how does exposure to early diseases accelerate the age-related decline in health?

Authors:  Ronald A Kohanski; Steven G Deeks; Claudia Gravekamp; Jeffrey B Halter; Kevin High; Arti Hurria; Rebecca Fuldner; Paige Green; Robin Huebner; Francesca Macchiarini; Felipe Sierra
Journal:  Ann N Y Acad Sci       Date:  2016-12-01       Impact factor: 5.691

4.  Geroscience: linking aging to chronic disease.

Authors:  Brian K Kennedy; Shelley L Berger; Anne Brunet; Judith Campisi; Ana Maria Cuervo; Elissa S Epel; Claudio Franceschi; Gordon J Lithgow; Richard I Morimoto; Jeffrey E Pessin; Thomas A Rando; Arlan Richardson; Eric E Schadt; Tony Wyss-Coray; Felipe Sierra
Journal:  Cell       Date:  2014-11-06       Impact factor: 41.582

5.  Particulate matter and episodic memory decline mediated by early neuroanatomic biomarkers of Alzheimer's disease.

Authors:  Diana Younan; Andrew J Petkus; Keith F Widaman; Xinhui Wang; Ramon Casanova; Mark A Espeland; Margaret Gatz; Victor W Henderson; JoAnn E Manson; Stephen R Rapp; Bonnie C Sachs; Marc L Serre; Sarah A Gaussoin; Ryan Barnard; Santiago Saldana; William Vizuete; Daniel P Beavers; Joel A Salinas; Helena C Chui; Susan M Resnick; Sally A Shumaker; Jiu-Chiuan Chen
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

Review 6.  Aging biomarkers and the brain.

Authors:  Albert T Higgins-Chen; Kyra L Thrush; Morgan E Levine
Journal:  Semin Cell Dev Biol       Date:  2021-01-25       Impact factor: 7.499

7.  Alzheimer's disease risk assessment using large-scale machine learning methods.

Authors:  Ramon Casanova; Fang-Chi Hsu; Kaycee M Sink; Stephen R Rapp; Jeff D Williamson; Susan M Resnick; Mark A Espeland
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

Review 8.  Ten Years of BrainAGE as a Neuroimaging Biomarker of Brain Aging: What Insights Have We Gained?

Authors:  Katja Franke; Christian Gaser
Journal:  Front Neurol       Date:  2019-08-14       Impact factor: 4.003

9.  Comparing data-driven and hypothesis-driven MRI-based predictors of cognitive impairment in individuals from the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Ramon Casanova; Fang-Chi Hsu; Ryan T Barnard; Andrea M Anderson; Rajesh Talluri; Christopher T Whitlow; Timothy M Hughes; Michael Griswold; Kathleen M Hayden; Rebecca F Gottesman; Lynne E Wagenknecht
Journal:  Alzheimers Dement       Date:  2021-07-26       Impact factor: 16.655

10.  Identifying Biomarkers for Biological Age: Geroscience and the ICFSR Task Force.

Authors:  N K LeBrasseur; R de Cabo; R Fielding; L Ferrucci; L Rodriguez-Manas; J Viña; B Vellas
Journal:  J Frailty Aging       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.